Publications

Export 49 results:
Sort by: [ Author (Desc)] Title Type Year
Filters: First Letter Of Last Name is J  [Clear All Filters]
A B C D E F G H I [J] K L M N O P Q R S T U V W X Y Z   [Show ALL]
J
Justesen J, Mosekilde L, Holmes M, Stenderup K, Gasser J, Mullins JJ, et al. Mice deficient in 11beta-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation. Endocrinology. 2004;145:1916-25. Abstract
Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol. 1990;259(4 Pt 2):H1038-43. Abstract
Joyner CD, Peters RJ, Afzal R, Chrolavicius S, Mehta SR, Fox KA, et al. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. Am Heart J. 2009;157(3):502-8. Abstract
Josephson CB, Frantzias J, Samarasekera N, Al-Shahi Salman R. The persisting burden of intracerebral haemorrhage: can effective treatments be found? PLoS Med. 2010;7(10):e1000353.
Josephson CB, Al-Shahi Salman R, Phillips SJ. An episode of transient neurological symptoms. BMJ. 2009;338:b616.
Jones ME, McInnes KJ, Boon WC, Simpson ER. Estrogen and adiposity--utilizing models of aromatase deficiency to explore the relationship. J Steroid Biochem Mol Biol. 2007;106(1-5):3-7. Abstract
Jones HA, Valind SO, Clark IC, Bolden GE, Krausz T, Schofield JB, et al. Kinetics of lung macrophages monitored in vivo following particulate challenge in rabbits. Toxicology and applied pharmacology. 2002;183:46-54. Abstract
Jolly SS, Shenkman H, Brieger D, Fox KA, Yan AT, Eagle KA, et al. Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events. Heart. 2011;97(3):197-202. Abstract
Jolly SS, Faxon DP, Fox KA, Afzal R, Boden WE, Widimsky P, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 trial. J Am Coll Cardiol. 2009;54(5):468-76. Abstract
Jokubaitis VJ, Sinka L, Driessen R, Whitty G, Haylock DN, Bertoncello I, et al. Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood. 2008;111(8):4055-63. Abstract
Johnstone AM, Faber P, Andrew R, Gibney ER, Elia M, Lobley G, et al. Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese men. European journal of endocrinology / European Federation of Endocrine Societies. 2004;150:185-94. Abstract
Johnston AR, Seckl JR, Dutia MB. Role of the flocculus in mediating vestibular nucleus neuron plasticity during vestibular compensation in the rat. The Journal of physiology. 2002;545:903-11. Abstract
Johansson IM, Bjartmar L, Marcusson J, Ross SB, Seckl JR, Olsson T. Chronic amitriptyline treatment induces hippocampal NGFI-A, glucocorticoid receptor and mineralocorticoid receptor mRNA expression in rats. Brain research. Molecular brain research. 1998;62:92-5. Abstract
Johansson A, Marroni F, Hayward C, Franklin CS, Kirichenko AV, Jonasson I, et al. Common variants in the JAZF1 gene associated with height identified by linkage and genome-wide association analysis. Hum Mol Genet. 2009;18(2):373-80. Abstract
Johansson A, Olsson T, Cederquist K, Forsberg H, Holst JJ, Seckl JR, et al. Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy. European journal of endocrinology / European Federation of Endocrine Societies. 2002;146:397-405. Abstract
Johansson IM, Wester P, Háková M, Gu W, Seckl JR, Olsson T. Early and delayed induction of immediate early gene expression in a novel focal cerebral ischemia model in the rat. The European journal of neuroscience. 2000;12:3615-25. Abstract
Jernigan NL, O’Donaughy TL, Walker BR. Correlation of HO-1 expression with onset and reversal of hypoxia-induced vasoconstrictor hyporeactivity. American journal of physiology. Heart and circulatory physiology. 2001;281:H298-307. Abstract
Jennings KA, Sheward WJ, Harmar AJ, Sharp T. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function. Neuropharmacology. 2008;54(5):776-83. Abstract
Jennings KA, Loder MK, Sheward JW, Pei Q, Deacon RM, Benson MA, et al. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2006;26:8955-64. Abstract
Jennings KA, Sheward WJ, Harmar AJ, Sharp T. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function. Neuropharmacology. 2008;54:776-83. Abstract
Jeanes H, Newby D, Gray GA. Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches. Expert opinion on pharmacotherapy. 2007;8:279-88. Abstract
Jeanes HL, Tabor C, Black D, Ederveen A, Gray GA. Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)alpha agonist and unaffected by an ER beta antagonist. The Journal of endocrinology. 2008;197:493-501. Abstract
Jeanes HL, Wanikiat P, Sharif I, Gray GA. Medroxyprogesterone acetate inhibits the cardioprotective effect of estrogen in experimental ischemia-reperfusion injury. Menopause. 2006;13(1):80-6. Abstract
Jarvis S, Moinard C, Robson SK, Baxter E, Ormandy E, Douglas AJ, et al. Programming the offspring of the pig by prenatal social stress: neuroendocrine activity and behaviour. Hormones and behavior. 2006;49:68-80. Abstract
Japp AG, Newby DE. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochemical pharmacology. 2008;75:1882-92. Abstract